Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 9,976 |
| Other current assets | 0 | 0 | 0 | 552 |
| TOTAL | $0 | $0 | $0 | $10,528 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 2,766 |
| Other Non-Current Assets | 0 | 0 | 0 | 550 |
| TOTAL | $N/A | $N/A | $N/A | $3,316 |
| Total Assets | $0 | $0 | $0 | $15,647 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 0 | 0 | 0 | 1,522 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 3,518 |
| Accrued Expenses | 0 | 0 | 0 | 2,112 |
| TOTAL | $0 | $0 | $0 | $17,926 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $0 | $21,250 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | 0 | -63,787 |
| Other shareholders' equity | 0 | 0 | 0 | 53,174 |
| TOTAL | $0 | $0 | $0 | $-5,603 |
| Total Liabilities And Equity | $0 | $0 | $0 | $15,647 |